Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 14, 2014 - Issue 1
Submit an article Journal homepage
159
Views
7
CrossRef citations to date
0
Altmetric
Research Reports

Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor

Afschin GandjourFrankfurt School of Finance & Management, Frankfurt, GermanyCorrespondence[email protected]
,
Amiram GafniMcMaster University, Hamilton, ON L8S 4L8, Canada
&
Michael SchlanderUniversity of Heidelberg, Mannheim, Germany
Pages 123-129 | Published online: 20 Dec 2013

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Frank G. Sandmann, Sarah Mostardt, Stefan K. Lhachimi & Andreas Gerber-Grote. (2018) The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?. Expert Review of Pharmacoeconomics & Outcomes Research 18:5, pages 475-486.
Read now

Articles from other publishers (6)

Florian Jakobs, Julia Jeck, Paymon Ahmadi, Anna Kron & Florian Kron. (2022) Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier. Cost Effectiveness and Resource Allocation 20:1.
Crossref
Jörg Mahlich, Isao Kamae & Bruno Rossi. (2017) A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM FOR JAPAN? SIMULATING THE POTENTIAL IMPACT ON THE PRICE OF SIMEPREVIR. International Journal of Technology Assessment in Health Care 33:1, pages 121-127.
Crossref
L. Wallentin, A. Himmelmann, R. F. Storey, P. G. Steg & R. A. Harrington. (2014) Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value. Thrombosis and Haemostasis 112:1.
Crossref
Lars Wallentin, Anders Himmelmann, Robert F. Storey, Philippe Steg & Robert A. Harrington. (2017) Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value. Thrombosis and Haemostasis 112:07, pages 12-14.
Crossref
Andreas Gerber-Grote, Frank Gerd Sandmann, Min Zhou, Corinna ten Thoren, Anja Schwalm, Carolin Weigel, Christiane Balg, Alexander Mensch, Sarah Mostardt, Astrid Seidl & Stefan K. Lhachimi. (2014) Decision making in Germany: Is health economic evaluation as a supporting tool a sleeping beauty?. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 108:7, pages 390-396.
Crossref
Afschin Gandjour. (2014) A theoretical and empirical investigation into the willingness-to-pay function for new innovative drugs by Germany’s health technology assessment agency (IQWiG). Health Services Management Research 26:4, pages 103-109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.